LINCOLN

Lincoln Pharmaceuticals LimitedNSE
₹599-2.75 (-0.46%)

Market Closed · NSE · INR

Open

₹599.05

High

₹600.45

Low

₹590.05

Prev Close

₹601.75

52-Week Range49% from low
₹444.2
₹758.15

Market Cap

₹1195.77 Cr

Small Cap

P/E (TTM)

13.6

EPS

₹43.89

Div Yield

0.30%

P/B Ratio

1.58

ROE

11.6%

Key Metrics

Forward P/E-
Book Value₹378.25
Debt/Equity0.01×
Revenue Growth11.3%
Profit Margin6.21%
Operating Margin14.56%
Volume20.4 K
Avg Volume (20d)41.0 K
Delivery %66.48%
Trades1,101

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypert...

lincolnpharma.com1,853 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 1.80/share
22
23
24
25
12 Sept 20251.80
13 Sept 20241.80
15 Sept 20231.50
15 Sept 20221.50
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.